FibroBiologics to Present Corporate Update at 2023 BIO International Convention

/PRNewswire/ -- FibroBiologics, a clinical-stage company focused on the development of fibroblast cell-based therapeutics for chronic diseases, today announced...

Related Keywords

Houston ,Texas ,United States ,Boston ,Massachusetts ,Pete Oheeron ,Prnewswire Fibrobiologics ,International Convention ,Boston Convention Exhibition Center ,Stage Company Focused On Advancing Fibroblast Cell ,Clinical Stage Company Focused ,Advancing Fibroblast Cell Based Therapies ,Peteo Heeron ,Chief Executive Officer ,Session Room ,Boston Convention ,One Partnering ,Fibrobiologics ,